XML 42 R24.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Other income | 12 Months Ended
--- | ---
Dec. 31, 2021
Other income | NOTE 16—Other income:
|  | Year ended December 31, |
|  | 2021 |  |  | 2020 |  |  | 2019 |
|  | (U.S. $ in millions) |
Gain on divestitures, net of divestitures related costs (1) |  |  | 51 |  |  |  | 8 |  |  |  | 50 |
Section 8 and similar payments (2) |  |  | 19 |  |  |  | — |  |  |  | 5 |
Gain (loss) on sale of assets |  |  | 7 |  |  |  | 11 |  |  |  | (1 | )
Other, net |  |  | 22 |  |  |  | 20 |  |  |  | 22 |
Total other income |  | $ | 98 |  |  | $ | 40 |  |  | $ | 76 |
(1) | In 2021, mainly due to capital gains related to the sale of certain OTC assets. In 2020 and 2019, mainly related to the divestment of several activities in the International Markets segment.
(2) | Section 8 of the Patented Medicines (Notice of Compliance) Regulation relates to recoveries of lost revenue related to patent infringement proceedings in Canada.

X
- Definition The entire disclosure for other operating income and other operating expense items. + References No definition available. + Details
Name: | us-gaap_OtherOperatingIncomeAndExpenseTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration